Task: Answer the multiple-choice question.
Query: Which drug exhibits a -24.016% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CN(C)c1nc(N)c([N+](=O)[O-])c(N2CCCCCC2)n1
b. O=c1c(Cl)c(NCc2ccccc2)cnn1C12CC3CC(CC(C3)C1)C2
Answer: b. O=c1c(Cl)c(NCc2ccccc2)cnn1C12CC3CC(CC(C3)C1)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=c1c(Cl)c(NCc2ccccc2)cnn1C12CC3CC(CC(C3)C1)C2
O=c1c(Cl)c(NCc2ccccc2)cnn1C12CC3CC(CC(C3)C1)C2
2-(1-adamantyl)-5-(benzylamino)-4-chloropyridazin-3-one